• Molecular NameFludiazepam
  • SynonymFludiazepamum [inn-latin]
  • Weight302.736
  • Drugbank_IDDB01567
  • ACS_NO3900-31-0
  • Show 3D model
  • LogP (experiment)2.75
  • LogP (predicted, AB/LogP v2.0)2.82
  • pkaN/A
  • LogD (pH=7, predicted)2.82
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.25
  • LogSw (predicted, AB/LogsW2.0)0.03
  • Sw (mg/ml) (predicted, ACD/Labs)0.02
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds1
  • TPSA32.67
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA drug which is a benzodiazepine derivative and is closely related to diazepam.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A